Mapping the resilience performance of community pharmacy to maintain patient safety during the Covid-19 pandemic.
COVID-19 pandemic
Community pharmacy
Patient safety
Resilient healthcare
Safety II
Journal
Research in social & administrative pharmacy : RSAP
ISSN: 1934-8150
Titre abrégé: Res Social Adm Pharm
Pays: United States
ID NLM: 101231974
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
received:
27
08
2021
revised:
07
01
2022
accepted:
08
01
2022
pubmed:
28
1
2022
medline:
26
7
2022
entrez:
27
1
2022
Statut:
ppublish
Résumé
The first UK wave of the Covid-19 pandemic in 2020 placed unprecedented stress on community pharmacy. Various policies and initiatives were announced during this period to support community pharmacy to continue to perform in a manner that prioritised patient safety. However, little is understood about how these policies and initiatives were implemented by staff working in community pharmacy, and the system adaptions and responses that were initiated to maintain patient safety. The study aimed to investigate how staff working in UK community pharmacy during the first waves of the COVID-19 pandemic in 2020 responded and adapted to system stressors to maintain patient safety. We adopted a qualitative interview approach, underpinned by Resilient Healthcare theory, with interview data collected between July 2020 and January 2021. Data were synthesised and analysed using Framework Analysis. 23 community pharmacy staff from England and Scotland were interviewed. We identified five themes supported by between two and six sub-themes: 1. Covid-19, an impending threat to system; 2. Patient safety stressors during the first waves of Covid-19; 3. Altering the system, responding to system stressors; 4. Monitoring and adjusting and 5. Learning for the future. Privileging the accounts of community pharmacy staff working on the frontline during the pandemic illuminated how responses and adaptions were developed and deployed, how continual monitoring occurred, and the factors that supported or hindered system resilience. The key learning derived from this study can serve to shorten the gap between 'work as imagined' and 'work as done', and in doing so, support the future resilience performance of community pharmacy during future outbreaks of Covid-19 or similar events.
Sections du résumé
BACKGROUND
The first UK wave of the Covid-19 pandemic in 2020 placed unprecedented stress on community pharmacy. Various policies and initiatives were announced during this period to support community pharmacy to continue to perform in a manner that prioritised patient safety. However, little is understood about how these policies and initiatives were implemented by staff working in community pharmacy, and the system adaptions and responses that were initiated to maintain patient safety.
OBJECTIVE
The study aimed to investigate how staff working in UK community pharmacy during the first waves of the COVID-19 pandemic in 2020 responded and adapted to system stressors to maintain patient safety.
METHODS
We adopted a qualitative interview approach, underpinned by Resilient Healthcare theory, with interview data collected between July 2020 and January 2021. Data were synthesised and analysed using Framework Analysis.
RESULTS
23 community pharmacy staff from England and Scotland were interviewed. We identified five themes supported by between two and six sub-themes: 1. Covid-19, an impending threat to system; 2. Patient safety stressors during the first waves of Covid-19; 3. Altering the system, responding to system stressors; 4. Monitoring and adjusting and 5. Learning for the future.
CONCLUSION
Privileging the accounts of community pharmacy staff working on the frontline during the pandemic illuminated how responses and adaptions were developed and deployed, how continual monitoring occurred, and the factors that supported or hindered system resilience. The key learning derived from this study can serve to shorten the gap between 'work as imagined' and 'work as done', and in doing so, support the future resilience performance of community pharmacy during future outbreaks of Covid-19 or similar events.
Identifiants
pubmed: 35082103
pii: S1551-7411(22)00004-3
doi: 10.1016/j.sapharm.2022.01.004
pmc: PMC8762922
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3534-3541Subventions
Organisme : Department of Health
Pays : United Kingdom
Informations de copyright
Crown Copyright © 2022. Published by Elsevier Inc. All rights reserved.
Références
Int J Clin Pract. 2021 Sep;75(9):e14421
pubmed: 34053167
Int J Clin Pharm. 2020 Aug;42(4):1197-1206
pubmed: 32524513
BMJ Open. 2019 Feb 19;9(2):e023440
pubmed: 30782879
Res Social Adm Pharm. 2021 Jan;17(1):1867-1875
pubmed: 32499160
BMC Health Serv Res. 2020 Apr 17;20(1):324
pubmed: 32303209
Can Pharm J (Ott). 2020 Aug 14;153(5):243-251
pubmed: 33106756
Res Social Adm Pharm. 2021 Jan;17(1):1882-1887
pubmed: 32499159
Res Social Adm Pharm. 2021 Jan;17(1):2032-2035
pubmed: 32245691
Res Social Adm Pharm. 2021 Jan;17(1):1967-1977
pubmed: 32389631
Int J Pharm Pract. 2020 Oct;28(5):415-416
pubmed: 32979248
Res Social Adm Pharm. 2021 Jan;17(1):1888-1896
pubmed: 32417070
BMC Health Serv Res. 2020 Apr 19;20(1):330
pubmed: 32306981
Res Social Adm Pharm. 2021 Jan;17(1):1832-1837
pubmed: 33317761
Res Social Adm Pharm. 2021 Feb;17(2):456-459
pubmed: 32387229
BMC Health Serv Res. 2020 Oct 2;20(1):913
pubmed: 33008384
Ir J Psychol Med. 2020 Sep;37(3):198-203
pubmed: 32434603
Disaster Med Public Health Prep. 2022 Oct;16(5):1864-1872
pubmed: 33588970